272 related articles for article (PubMed ID: 33216263)
1. Pressurized Intraperitoneal Aerosol Chemotherapy Enhanced by Electrostatic Precipitation (ePIPAC) for Patients with Peritoneal Metastases.
Taibi A; Teixeira Farinha H; Durand Fontanier S; Sayedalamin Z; Hübner M; Sgarbura O
Ann Surg Oncol; 2021 Jul; 28(7):3852-3860. PubMed ID: 33216263
[TBL] [Abstract][Full Text] [Related]
2. Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient.
Graversen M; Detlefsen S; Ellebaek SB; Fristrup C; Pfeiffer P; Mortensen MB
Eur J Surg Oncol; 2020 Jan; 46(1):155-159. PubMed ID: 31493986
[TBL] [Abstract][Full Text] [Related]
3. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
[TBL] [Abstract][Full Text] [Related]
4. Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
Lurvink RJ; Tajzai R; Rovers KP; Wassenaar ECE; Moes DAR; Pluimakers G; Boerma D; Burger JWA; Nienhuijs SW; de Hingh IHJT; Deenen MJ
Ann Surg Oncol; 2021 Jan; 28(1):265-272. PubMed ID: 32572849
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC).
Kakchekeeva T; Demtröder C; Herath NI; Griffiths D; Torkington J; Solaß W; Dutreix M; Reymond MA
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):592-598. PubMed ID: 26842487
[TBL] [Abstract][Full Text] [Related]
6. Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy.
Roussin F; Taibi A; Canal-Raffin M; Cantournet L; Durand-Fontanier S; Druet-Cabanac M; El Balkhi S; Maillan G
Eur J Surg Oncol; 2021 Nov; 47(11):2939-2947. PubMed ID: 34034944
[TBL] [Abstract][Full Text] [Related]
7. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
[TBL] [Abstract][Full Text] [Related]
8. First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II).
Lurvink RJ; Rauwerdink P; Rovers KP; Wassenaar ECE; Deenen MJ; Nederend J; Huysentruyt CJR; van 't Erve I; Fijneman RJA; van der Hoeven EJRJ; Seldenrijk CA; Constantinides A; Kranenburg O; Los M; Herbschleb KH; Thijs AMJ; Creemers GM; Burger JWA; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
BMJ Open; 2021 Mar; 11(3):e044811. PubMed ID: 33785492
[TBL] [Abstract][Full Text] [Related]
9. Electrostatic precipitation Pressurized IntraPeritoneal Aerosol Chemotherapy (ePIPAC): first in-human application.
Reymond M; Demtroeder C; Solass W; Winnekendonk G; Tempfer C
Pleura Peritoneum; 2016 Jun; 1(2):109-116. PubMed ID: 30911614
[No Abstract] [Full Text] [Related]
10. Safety and preliminary efficacy of electrostatic precipitation during pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable carcinomatosis.
Willaert W; Van de Sande L; Van Daele E; Van De Putte D; Van Nieuwenhove Y; Pattyn P; Ceelen W
Eur J Surg Oncol; 2019 Dec; 45(12):2302-2309. PubMed ID: 31221459
[TBL] [Abstract][Full Text] [Related]
11. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.
Demtröder C; Solass W; Zieren J; Strumberg D; Giger-Pabst U; Reymond MA
Colorectal Dis; 2016 Apr; 18(4):364-71. PubMed ID: 26400556
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Van de Sande L; Willaert W; Cosyns S; De Clercq K; Shariati M; Remaut K; Ceelen W
BMC Cancer; 2019 May; 19(1):424. PubMed ID: 31064330
[TBL] [Abstract][Full Text] [Related]
13. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study.
Struller F; Horvath P; Solass W; Weinreich FJ; Strumberg D; Kokkalis MK; Fischer I; Meisner C; Königsrainer A; Reymond MA
Ther Adv Med Oncol; 2019; 11():1758835919846402. PubMed ID: 31205501
[TBL] [Abstract][Full Text] [Related]
14. Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study.
Tempfer CB; Rezniczek GA; Ende P; Solass W; Reymond MA
Anticancer Res; 2015 Dec; 35(12):6723-9. PubMed ID: 26637888
[TBL] [Abstract][Full Text] [Related]
15. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
Robella M; Vaira M; De Simone M
World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
[TBL] [Abstract][Full Text] [Related]
16. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
[TBL] [Abstract][Full Text] [Related]
17. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
Odendahl K; Solass W; Demtröder C; Giger-Pabst U; Zieren J; Tempfer C; Reymond MA
Eur J Surg Oncol; 2015 Oct; 41(10):1379-85. PubMed ID: 26138283
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study.
Sgarbura O; Hübner M; Alyami M; Eveno C; Gagnière J; Pache B; Pocard M; Bakrin N; Quénet F
Eur J Surg Oncol; 2019 Dec; 45(12):2386-2391. PubMed ID: 31092362
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer.
Sindayigaya R; Dogan C; Demtröder CR; Fischer B; Karam E; Buggisch JR; Tempfer CB; Lecomte T; Ouaissi M; Giger-Pabst U
Ann Surg Oncol; 2022 Jan; 29(1):112-123. PubMed ID: 34611790
[TBL] [Abstract][Full Text] [Related]
20. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
Alyami M; Bonnot PE; Mercier F; Laplace N; Villeneuve L; Passot G; Bakrin N; Kepenekian V; Glehen O
Eur J Surg Oncol; 2021 Jan; 47(1):123-127. PubMed ID: 32561204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
